interferon

systematic review meta-analysis network meta-analysis

Select melanoma adjuvant settingAll type of patient       interferon Interferon alpha vs placebo or control      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	progression or death (progression free survival PFS) (18)death (overall survival) (16)distant metastasis free survival (8) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	progression or death (progression free survival PFS)	death (overall survival)
melanoma
Interferon alpha
EORTC18952 (Eggermont), 2005	ID IFN alpha-2b (I M)	observation	adjuvant			negative
Nordic IFN Trial, 2011	ID IFN alpha-2b (I M)	observation	adjuvant			suggesting
EORTC18991 (Eggermont), 2008	PEG IFN alpha-2b (I M)	observation	adjuvant			suggesting
EORTC18871/DKG 80-1 (Kleeberg), 2004	rIFN alpha-2b	observation	adjuvant			negative